Rebiotix Inc., a clinical-stage microbiome company focused on harnessing the power of the human microbiome to treat challenging diseases, today announced that three posters highlighting RBX2660...

Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, is presenting at ID Week 2017 additional data from...

Carlisle Interconnect Technologies (CarlisleIT), a division of Carlisle Companies (CSL), is exhibiting at the upcoming NBAA BACE Conference in Las Vegas, NV, Oct. 10 – 12, 2017 in booth number...

WHO/WHAT: Actifio CEO and Founder Ash Ashutosh will be keynoting at TiE StartupCON this Friday October 6, the largest conference of its kind in New England. Since 2009, Actifio, the Enterprise...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...